Marten Vågerö

Title: The Innovative Mind of Marten Vågerö

Introduction

Marten Vågerö, an accomplished inventor based in Saltsjö-Boo, Sweden, has made significant contributions to the field of infant nutrition. With a focus on enhancing the growth velocity of human infants, his innovative methods hold promise for improving the health and wellbeing of vulnerable infants, particularly those born preterm or underweight.

Latest Patents

Marten Vågerö holds a patent for a groundbreaking method to increase the growth velocity of human infants. This invention involves the enteral administration of recombinant human bile-salt-stimulated lipase (rhBSSL) to infants, which is particularly beneficial for those in medical need of accelerating their growth. The patent outlines various compositions, including infant feeds, pharmaceutical products, and kits, as well as methods to protect the small bowel mucosa and immature intestinal epithelium of infants from damage caused by incompletely digested fats or lipids.

Career Highlights

Marten is currently associated with Swedish Orphan Biovitrum AB (publ), a company renowned for its commitment to developing and delivering innovative treatments for patients with rare diseases. His work at this institution has solidified his reputation as a leading innovator in the realm of infant care and nutrition.

Collaborations

Throughout his career, Marten has collaborated with esteemed colleagues such as Olle Hernell and Birgitta Olsson. Their teamwork exemplifies the power of collaboration in advancing scientific research and developing impactful innovations.

Conclusion

Marten Vågerö's dedication to improving the health outcomes of infants through innovative methods and patented inventions marks him as a significant figure in the field of pediatric nutrition. His work not only contributes to the scientific community but also has the potential to change lives, ensuring a healthier future for infants in need.